Ignite Creation Date:
2024-05-06 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05212454
Status:
RECRUITING
Last Update Posted:
2023-04-25
First Post:
2022-01-15
Brief Title:
Efficacy of Supplement Adjuvant Capecitabine in HRHER2- Breast Cancer Patients With High Risks
Sponsor:
Second Affiliated Hospital School of Medicine Zhejiang University
Organization:
Second Affiliated Hospital School of Medicine Zhejiang University